Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • cjag
    Junior Member
    • Mar 2020
    • 1

    #1

    DESeq2 interaction term results differ between full dataset & subset

    Hi all, hoping someone has some insight on this because I am completely stumped...

    I'm using DESeq2 for differential analysis between 2 different experiment/sequencing types (wholly different methods, not like SE vs PE) and with multiple treatment conditions vs. one control condition. I do have a batch effect so I have to include that term in my design as well.
    ID Batch Condition SeqType
    1 1 ctrl X
    2 1 A X
    3 1 B X
    4 1 C X
    5 2 ctrl X
    6 2 A X
    7 2 B X
    8 2 C X
    9 1 ctrl Y
    10 1 A Y
    11 1 B Y
    12 1 C Y
    13 2 ctrl Y
    14 2 A Y
    15 2 B Y
    16 2 C Y


    So the design ends up being " ~ Batch + SeqType + Condition + Condition:SeqType "


    With reference levels for Condition=ctrl & SeqType=X, this gives me resultsNames of:
    • Intercept
    • Batch_2_vs_1
    • SeqType_Y_vs_X
    • Condition_A_vs_ctrl
    • Condition_B_vs_ctrl
    • Condition_C_vs_ctrl
    • SeqTypeY.ConditionA
    • SeqTypeY.ConditionB
    • SeqTypeY.ConditionC



    It's my understanding that using results(dds, name="SeqTypeY.ConditionA") should give me the genes for which changes (ie. A vs. ctrl) in sequencing type Y are independent of changes in sequencing type X.


    This analysis works and I get reasonable results for all of my conditions when I do not subset the data (i.e. conditions A, B, C, and ctrl are all in the same counts file input to the DESeqDataSet object, then results are called separately for each). However, when I subset by condition (i.e. input condition A & ctrl only), all the genes have padj>0.95 in the interaction term results.


    Does anyone know why this is happening or if it matters? I'm concerned it means I'm doing something wrong in the multiple conditions analysis?


    A related question - does the padj value correct for multiple comparisons between all genes within a specified results table (i.e. for all genes in the "SeqTypeY.ConditionA" results) or does it correct for multiple comparisons between all genes across all possible results tables (i.e. SeqTypeY.ConditionA vs. SeqTypeY.ConditionB vs. SeqTypeY.ConditionC)? I did the subset analysis because I was trying to answer this question for myself and I'm afraid I've just made my confusion worse....

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...